Indian equity indices were trading in the red territory on Thursday following the weak global market trend. The BSE Sensex fell 247 or 0.40% to 62,429.92 and NSE Nifty dipped 78.25 points or 0.42% to 18,582.05. IndusInd Bank, Sun Pharma, State Bank of India, Mahindra & Mahindra and NTPC were the top gainers on the Sensex while Tech Mahindra, Infosys, HCL Tech, TCS and UltraTech were the top losers...

Indian equity markets are likely to open gap-down on Monday as trends on SGX Nifty hinted at a negative opening for benchmark indices BSE Sensex and NSE Nifty 50. The Nifty futures were trading around 16,505 levels on the Singaporean exchange ahead of today’s session. “Markets have been witnessing a rebound for the last 3 weeks however the move lacks decisiveness due to lingering challenges...

Shares of Poonawalla Fincorp rallied nearly 16% to Rs250 apiece on the BSE in Friday's session after the company said its assets under management (AUM) for FY22 increased to Rs16,579 crore, recording a growth of 17% over FY21 while disbursements grew by 158% over FY21.Its consolidated profit before tax for FY22 stood at Rs492 crore against a loss of Rs749 crore in FY21. Net profit for FY22 came at...

Shares of Poonawalla Fincorp have surged from Rs40 per share level in January early year to over currently trading over Rs160 level currently as the multibagger stock has skyrocketed more than 300% this year (year-to-date). Brokerage firm ICICI Securities sees further upside on the stock after its second quarter results.The company reported better-than-expected net profit which grew 151% on a year...

As India scripted history on Thursday achieving the 100-crore vaccination milestone, Adar Poonawalla, chief executive officer of Serum Institute of India, who is responsible for nearly 90% of the total supplies of Covid-19 vaccine in India, shares with Teena Thacker his journey and how his company overcame a plethora of challenges to reach this milestone. Edited excerpts:How has the journey been s...